Investigating the role of ceramide metabolism associated CERS5 (LASS5) gene in atherosclerosis pathogenesis in endothelial cells
Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies have demonstrated protective role of AMP-activated protein kinase (AMPK) genes in regulating atherosclerosis and hypertension. Ceramide syntha...
Saved in:
Published in | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Vol. 45; no. 2; pp. 118 - 125 |
---|---|
Main Author | |
Format | Journal Article |
Language | English Turkish |
Published |
Turkey
KARE Publishing
01.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies have demonstrated protective role of AMP-activated protein kinase (AMPK) genes in regulating atherosclerosis and hypertension. Ceramide synthase 5 (LASS5 or CERS5) gene has function in de novo synthesis of ceramide, and has indirect effect on AMPK gene. Aim of the present study was to identify role of LASS5 gene in atherosclerosis.
LASS5 gene-specific small interfering RNA (siRNA)-mediated gene silencing was performed in human umbilical vein endothelial cells (HUVEC) and differential expression of LASS5, AMPK-alpha and AMPK-alpha target genes were analyzed. HUVEC cells were then treated with AMPK activator in order to examine relationship of change in gene expression levels to AMPK activity.
Novel physiological function of LASS5 was identified. Downregulation of LASS5 was found to attenuate ceramide production and increase expression of some AMPK target genes in HUVEC.
This is the first study to demonstrate that LASS5 was involved in negative regulation of atherosclerosis-related genes, such as AMPK-alpha. These preliminary findings provide insight into molecular mechanism of atherosclerosis and are important for development of potential therapeutic agents in the treatment of atherosclerosis. |
---|---|
AbstractList | Objective: Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies have demonstrated protective role of AMP-activated protein kinase (AMPK) genes in regulating atherosclerosis and hypertension. Ceramide synthase 5 (LASS5 or CERS5) gene has function in de novo synthesis of ceramide, and has indirect effect on AMPK gene. Aim of the present study was to identify role of LASS5 gene in atherosclerosis. Methods: LASS5 gene-specific small interfering RNA (siRNA)-mediated gene silencing was performed in human umbilical vein endothelial cells (HUVEC) and differential expression of LASS5, AMPK-alpha and AMPK-alpha target genes were analyzed. HUVEC cells were then treated with AMPK activator in order to examine relationship of change in gene expression levels to AMPK activity. Results: Novel physiological function of LASS5 was identified. Downregulation of LASS5 was found to attenuate ceramide production and increase expression of some AMPK target genes in HUVEC. Conclusion: This is the first study to demonstrate that LASS5 was involved in negative regulation of atherosclerosis-related genes, such as AMPK-alpha. These preliminary findings provide insight into molecular mechanism of atherosclerosis and are important for development of potential therapeutic agents in the treatment of atherosclerosis. Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies have demonstrated protective role of AMP-activated protein kinase (AMPK) genes in regulating atherosclerosis and hypertension. Ceramide synthase 5 (LASS5 or CERS5) gene has function in de novo synthesis of ceramide, and has indirect effect on AMPK gene. Aim of the present study was to identify role of LASS5 gene in atherosclerosis. LASS5 gene-specific small interfering RNA (siRNA)-mediated gene silencing was performed in human umbilical vein endothelial cells (HUVEC) and differential expression of LASS5, AMPK-alpha and AMPK-alpha target genes were analyzed. HUVEC cells were then treated with AMPK activator in order to examine relationship of change in gene expression levels to AMPK activity. Novel physiological function of LASS5 was identified. Downregulation of LASS5 was found to attenuate ceramide production and increase expression of some AMPK target genes in HUVEC. This is the first study to demonstrate that LASS5 was involved in negative regulation of atherosclerosis-related genes, such as AMPK-alpha. These preliminary findings provide insight into molecular mechanism of atherosclerosis and are important for development of potential therapeutic agents in the treatment of atherosclerosis. Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies have demonstrated protective role of AMP-activated protein kinase (AMPK) genes in regulating atherosclerosis and hypertension. Ceramide synthase 5 (LASS5 or CERS5) gene has function in de novo synthesis of ceramide, and has indirect effect on AMPK gene. Aim of the present study was to identify role of LASS5 gene in atherosclerosis.OBJECTIVECeramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies have demonstrated protective role of AMP-activated protein kinase (AMPK) genes in regulating atherosclerosis and hypertension. Ceramide synthase 5 (LASS5 or CERS5) gene has function in de novo synthesis of ceramide, and has indirect effect on AMPK gene. Aim of the present study was to identify role of LASS5 gene in atherosclerosis.LASS5 gene-specific small interfering RNA (siRNA)-mediated gene silencing was performed in human umbilical vein endothelial cells (HUVEC) and differential expression of LASS5, AMPK-alpha and AMPK-alpha target genes were analyzed. HUVEC cells were then treated with AMPK activator in order to examine relationship of change in gene expression levels to AMPK activity.METHODSLASS5 gene-specific small interfering RNA (siRNA)-mediated gene silencing was performed in human umbilical vein endothelial cells (HUVEC) and differential expression of LASS5, AMPK-alpha and AMPK-alpha target genes were analyzed. HUVEC cells were then treated with AMPK activator in order to examine relationship of change in gene expression levels to AMPK activity.Novel physiological function of LASS5 was identified. Downregulation of LASS5 was found to attenuate ceramide production and increase expression of some AMPK target genes in HUVEC.RESULTSNovel physiological function of LASS5 was identified. Downregulation of LASS5 was found to attenuate ceramide production and increase expression of some AMPK target genes in HUVEC.This is the first study to demonstrate that LASS5 was involved in negative regulation of atherosclerosis-related genes, such as AMPK-alpha. These preliminary findings provide insight into molecular mechanism of atherosclerosis and are important for development of potential therapeutic agents in the treatment of atherosclerosis.CONCLUSIONThis is the first study to demonstrate that LASS5 was involved in negative regulation of atherosclerosis-related genes, such as AMPK-alpha. These preliminary findings provide insight into molecular mechanism of atherosclerosis and are important for development of potential therapeutic agents in the treatment of atherosclerosis. |
Author | Coban, Neslihan |
Author_xml | – sequence: 1 givenname: Neslihan surname: Coban fullname: Coban, Neslihan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28424433$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UcFu3CAQRVWiJt3k3FvFMT14AwZsOEarNF1ppUrd5IzGgLekttkCG6m3fnpwNumhUjkMMPPeG5j3AZ1MYXIIfaRkKQRn1_mnhWVNaLOUNZPqHTqnjMiKcylPyrkUKkEbdYYuU3okZXHFqGjfo7Na8ppzxs7Rn_X05FL2O8h-2uH8w-EYBodDj42LMHrr8OgydGHwacSQUjAesrN4dft9K_DV5ma7FZ_xzk0O-wlDUYghmWGOPuF9SYS5OF9K3U02FMjgYSgNhiFdoNMehuQuX_cFevhye7_6Wm2-3a1XN5vK1Irlyghat8IaQsD0ykkQvBW9IV0jBe1NQxzpOkmMY9KCaE0jLefCENNCpyyv2QKtj7o2wKPeRz9C_K0DeP2SCHGnIWZfHq4NMOUa4C2jJQghVcv6xvSMsLoFMEXr6qi1j-HXoYxPjz7Nv4HJhUPSVCpKFOGFsECfXqGHbnT2b-M3BwpAHAGmDCxF12vjczEjTDmCHzQlejZbz2br2Wz9YnbhXf_De5P-H-MZmjKs7w |
CitedBy_id | crossref_primary_10_1134_S1022795422100039 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.5543/tkda.2016.82389 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Seramid metabolizması ile ilişkili CERS5 (LASS5) geninin endotel hücrelerinde ateroskleroz patogenezindeki rolünün araştırılması |
EISSN | 1308-4488 1016-5169 |
EndPage | 125 |
ExternalDocumentID | oai_doaj_org_article_ca39e6a4731a47558973f6cf30327aac 28424433 10_5543_tkda_2016_82389 |
Genre | Journal Article |
GroupedDBID | 53G 7X7 8FI 8FJ AAYXX ABUWG ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BCNDV BENPR CCPQU CITATION EMOBN F5P FYUFA GJB GROUPED_DOAJ HMCUK OK1 PHGZM PHGZT PIMPY SV3 SW3 UKHRP CGR CUY CVF ECM EIF M~E NPM 7X8 |
ID | FETCH-LOGICAL-c293t-c51275dc00acf9e8a5475fc0b6851fc60e0bb80ce38da57c68d445c0c7ab9d423 |
IEDL.DBID | DOA |
ISSN | 1016-5169 1308-4488 |
IngestDate | Wed Aug 27 01:30:33 EDT 2025 Fri Jul 11 07:23:32 EDT 2025 Thu Jan 02 22:25:23 EST 2025 Tue Jul 01 01:02:04 EDT 2025 Thu Apr 24 22:53:06 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English Turkish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c293t-c51275dc00acf9e8a5475fc0b6851fc60e0bb80ce38da57c68d445c0c7ab9d423 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/ca39e6a4731a47558973f6cf30327aac |
PMID | 28424433 |
PQID | 1891090430 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ca39e6a4731a47558973f6cf30327aac proquest_miscellaneous_1891090430 pubmed_primary_28424433 crossref_citationtrail_10_5543_tkda_2016_82389 crossref_primary_10_5543_tkda_2016_82389 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-03-01 |
PublicationDateYYYYMMDD | 2017-03-01 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Turkey |
PublicationPlace_xml | – name: Turkey |
PublicationTitle | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir |
PublicationTitleAlternate | Turk Kardiyol Dern Ars |
PublicationYear | 2017 |
Publisher | KARE Publishing |
Publisher_xml | – name: KARE Publishing |
SSID | ssj0000493157 ssib044763490 |
Score | 2.0601547 |
Snippet | Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role. Previous studies... Objective: Ceramide, the backbone of sphingolipids, is the key component affecting atherosclerotic changes through its important second-messenger role.... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 118 |
SubjectTerms | ampk atherosclerosis Atherosclerosis - metabolism Cells, Cultured ceramide; sirna Down-Regulation - drug effects Human Umbilical Vein Endothelial Cells - metabolism Humans lass5 RNA, Small Interfering - genetics RNA, Small Interfering - pharmacology Sphingosine N-Acyltransferase - genetics Sphingosine N-Acyltransferase - metabolism |
Title | Investigating the role of ceramide metabolism associated CERS5 (LASS5) gene in atherosclerosis pathogenesis in endothelial cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28424433 https://www.proquest.com/docview/1891090430 https://doaj.org/article/ca39e6a4731a47558973f6cf30327aac |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQqHwsUORKHMohrbOOv46l2qpClANLpd4ie2yjhd0ENekV8dOZSdLVcqh64WIlsSNbbyae52j8zNh7GSwI0L6oDAQssixsLn2hnHYx2gCgaYPz5Rd9cVV9ulbXO0d9UU7YKA88AncCXrqkfWVkiYVS1hmZNWSceufGe6DZF2PezmLqx8h7ZanMqOWDEVOe9D8jyQyV-thilHL_hKFBrf9-ijmEmvOn7MnEEfnpOLZn7FFq9tmfHUWM5jtH3sYpM5C3mUO68ZtVTHyTerTpetVtCj_BniI_W3xdKn70-XS5VB84Okziq4YPzK_tsAMsVx2no4lbqqQbrE9NpM1Za_RPTn_3u-fs6nzx7eyimI5PKABjeF-AIvH2CEJ4yC5ZrxC_DCJoZFkZtEgiBCsgSRu9MqBtrCqFljM-uIg06wXba9omvWI8znNWQXhsLSu8cAqUpw0-lbPGmzxjx3do1jBpi9MRF-sa1xgEf03w1wR_PcA_Y0fbF36Nshr3N_1I5tk2Iz3s4QF6ST15Sf2Ql8zY4Z1xa_x-CDbfpPa2q0vrKDe1kmLGXo5W33aFoRvZj5Sv_8cQ3rDHc6IEQ_7aW7bX39ymAyQ0fXg3-C6Wl78XfwFdHfVn |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Investigating+the+role+of+ceramide+metabolism-associated+CERS5+%28LASS5%29+gene+in+atherosclerosis+pathogenesis+in+endothelial+cells&rft.jtitle=Turk+Kardiyoloji+Dernegi+arsivi+%3A+Turk+Kardiyoloji+Derneginin+yayin+organidir&rft.au=%C3%87oban%2C+Neslihan&rft.au=G%C3%BC%C3%A7l%C3%BC+Geyik%2C+Filiz&rft.au=Y%C4%B1ld%C4%B1r%C4%B1m%2C+%C3%96zlem&rft.au=Erginel+%C3%9Cnaltuna%2C+Nihan&rft.date=2017-03-01&rft.issn=1308-4488&rft.eissn=1308-4488&rft.volume=45&rft.issue=2&rft.spage=118&rft_id=info:doi/10.5543%2Ftkda.2016.82389&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1016-5169&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1016-5169&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1016-5169&client=summon |